Early activation of lung NFkappaB and NF-IL6 and lung cytokine mRNA expression correlated with mortality in polymicrobial sepsis. Although IL-6 mRNA levels correlated with NFkappaB and NF-IL6 activation, tumor necrosis factor-alpha mRNA levels did not, in that they preceded transcription factor activation. These data suggest a potential role for NFkappaB and NF-IL6 activation in the initiation and propagation of acute lung injury.
1. In a randomized, double-blind 6-month study, a-tocopherol (728 mg) or placebo were administered daily to seventy-eight volunteers (forty-nine men, twenty-nine women) to investigate the possible enhancing effect of vitamin E on plasma high-density-lipoprotein-cholesterol (HDL-C) levels. In addition, the available reported values from short-term (4-6 weeks) studies, as well as the 4-week results from the present study, were combined and analysed for factors which may modify the effect of a-tocopherol on HDL-C.2. No consistent effect of a-tocopherol on plasma HDL-C levels was observed either in the combined 4-week values or in the 6-month study. Further analysis of the combined short-term values and 6-month values indicated that, in subjects with low initial HDL-C levels, treatment with a-tocopherol or placebo did not produce significantly different HDL-C changes.Results of some preliminary short-term studies have suggested that administration of a large daily dose of a-tocopherol (545-728 mg) can increase the plasma levels of high-densitylipoprotein-cholesterol (HDL-C) (Herman et al. 1979;. In view of the reported attenuating effects of high HDL-C levels on the development of coronary heart disease and the relative difficulty in achieving a significant and reproducible rise in HDL-C by dietary or pharmacologic means, the reports on the effect of a-tocopherol on this lipid class attracted considerable attention. However, a series of other studies (Schwartz & Rutherford, 1981;Barboriak et al. 1982;Ehnholm et al. 1982;Howard et al. 1982; Kesaniemi & Grundy, 1982; Chapkin et al. 1983;Serfontein et al. 1983), employing relatively small groups of subjects, failed to confirm the general effectiveness of a-tocopherol on HDL-C levels. Few of the reports were based on controlled randomized trials that included a placebo group, and they used a short (4-6 weeks) treatment period.Therefore, we decided to study the effect of a-tocopherol on plasma HDL-C levels in a long-term, double-blind study using patients most likely to benefit from such a treatment, i.e. patients entering a cardiac rehabilitation programme. In addition, we have pooled available reported short-term values on the effect of a-tocopherol on plasma HDL-C in order to investigate the possible variables modifying such an effect. The findings of both the long-term and pooled-values studies indicate little or no consistent effect of oral a-tocopherol on plasma HDL-C levels.
M A T E R I A L S A N D M E T H O D SLong-term study Subject selection. A group of forty-nine male patients (24-73 years of age), who were enrolled in a cardiac rehabilitation programme, volunteered for the study. A group of twenty-nine female subjects (24-71 years of age), who were spouses of the male patients, https://www.cambridge.org/core/terms. https://doi
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.